The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease-Reference-Cited by-同舟云学术

The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease

Published:2024-06-15 Issue: Volume: Page:
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Wu Meiyan^ORCID,Yoon Chang-Yun,Park Jimin,Kim Gyuri,Nam Bo Young,Kim Seonghun^ORCID,Park Jung Tak^ORCID,Han Seung Hyeok^ORCID,Kang Shin-Wook,Yoo Tae-Hyun^ORCID

Funder

Postdoctoral Science Foundation of China

the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea

National Research Foundation of Korea

National Natural Science Foundation of China

Natural Science Foundation of Jilin Province, China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00125-024-06191-8.pdf

Reference47 articles.

1. Umanath K, Lewis JB (2018) Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis 71:884–895. https://doi.org/10.1053/j.ajkd.2017.10.026

2. Kwon S, Hyeon JS, Jung Y et al (2023) Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance. Kidney Res Clin Pract 42:445–459. https://doi.org/10.23876/j.krcp.22.152

3. Kim DW, Song SH (2023) A new journey to predict the prognosis of diabetic kidney disease. Kidney Res Clin Pract 42:409–411. https://doi.org/10.23876/j.krcp.23.093

4. Kimmelstiel P, Wilson C (1936) Intercapillary lesions in the glomeruli of the kidney. Am J Pathol 12:83-98.7

5. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M (2006) Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55:2502–2509. https://doi.org/10.2337/db05-0603